Cargando…
FABP5, a Novel Immune-Related mRNA Prognostic Marker and a Target of Immunotherapy for Multiple Myeloma
Objective: Multiple myeloma is an incurable hematological malignancy. It is imperative to identify immune markers for early diagnosis and therapy. Here, this study analyzed immune-related mRNAs and assessed their prognostic value and therapeutic potential. Methods: Abnormally expressed immune-relate...
Autores principales: | Jia, Haipeng, Zhang, Xiaofen, Liu, Xinxin, Qiao, Ruifang, Liu, Yan, Lv, Sulong, Zhu, Hongbo, Wang, Jie, Kong, Qiuhong, Zhang, Hong, Zhang, Zhirong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266212/ https://www.ncbi.nlm.nih.gov/pubmed/34249967 http://dx.doi.org/10.3389/fmed.2021.667525 |
Ejemplares similares
-
LBX2-AS1 as a Novel Diagnostic Biomarker and Therapeutic Target Facilitates Multiple Myeloma Progression by Enhancing mRNA Stability of LBX2
por: Jia, Haipeng, et al.
Publicado: (2021) -
Identification of FABP5 as an immunometabolic marker in human hepatocellular carcinoma
por: Liu, Fangming, et al.
Publicado: (2020) -
FABP1 and FABP2 as markers of diabetic nephropathy
por: Tsai, I-Ting, et al.
Publicado: (2020) -
Structural Insights into Mouse H-FABP
por: Wang, Lili, et al.
Publicado: (2022) -
High expression of FABP4 and FABP6 in patients with colorectal cancer
por: Zhang, Yaqin, et al.
Publicado: (2019)